Background The numbers of confirmed cases of coronavirus disease 2019 (COVID-19) and
COVID-19 related deaths are still increasing, so it is very important to determine the risk …

Background and aims The number of positive and death cases from coronavirus disease
2019 (COVID-19) is still increasing. The identification of risk factors for severe outcomes is …

Objective: This systematic review and meta-analysis aimed to evaluate whether
dyslipidemia affects the mortality and severity of COVID-19, we also aimed to evaluate …

Background The prevalence and prognostic implications of pre-existing dyslipidaemia in
patients infected by the SARS-CoV-2 remain unclear. Aim To assess the prevalence and …

Objective The aim of this study was to analyze the available knowledge about the potential
association between dyslipidemia and the severity of coronavirus disease 2019 (COVID-19) …

People with comorbid conditions are at increased risk of developing severe/fatal coronavirus
disease 2019 (COVID-19). We aimed to investigate the relationship between lipid levels and …

Background Coronavirus disease 2019 (COVID-19) ranges from asymptomatic infection to
severe illness. Cholesterol in the host cell plasma membrane plays an important role in the …

Lipid profile alterations have been observed in patients with coronavirus disease 2019
(COVID-19) in relation to disease severity and mortality. We conducted a systematic review …

Summary Background Coronavirus disease-2019 (COVID-19) is a global pandemic. Studies
reported dyslipidemia in patients with COVID-19. Herein, we conducted a systematic review …

Background It has been reported that dyslipidemia is related to coronavirus-related
diseases. Critical patients with coronavirus disease 2019 (COVID-19) who suffered from …